Barclays’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2M Buy
97,490
+45,620
+88% +$4.76M ﹤0.01% 1147
2025
Q1
$6.05M Sell
51,870
-46,118
-47% -$5.38M ﹤0.01% 1303
2024
Q4
$8.29M Buy
97,988
+36,203
+59% +$3.06M ﹤0.01% 1242
2024
Q3
$5.55M Buy
61,785
+45,509
+280% +$4.09M ﹤0.01% 1455
2024
Q2
$1.31M Sell
16,276
-203,822
-93% -$16.4M ﹤0.01% 1962
2024
Q1
$17.6M Buy
220,098
+28,236
+15% +$2.25M 0.01% 784
2023
Q4
$15.3M Buy
191,862
+175,052
+1,041% +$13.9M 0.01% 832
2023
Q3
$1.18M Buy
16,810
+16,737
+22,927% +$1.17M ﹤0.01% 1971
2023
Q2
$5K Buy
+73
New +$5K ﹤0.01% 4108
2022
Q4
Sell
-26,572
Closed -$1.19M 4375
2022
Q3
$1.19M Buy
+26,572
New +$1.19M ﹤0.01% 2009
2021
Q4
Sell
-1,571
Closed -$52K 3263
2021
Q3
$52K Sell
1,571
-52,146
-97% -$1.73M ﹤0.01% 3374
2021
Q2
$3.62M Buy
53,717
+18,681
+53% +$1.26M ﹤0.01% 1378
2021
Q1
$1.98M Buy
35,036
+23,604
+206% +$1.34M ﹤0.01% 1864
2020
Q4
$931K Hold
11,432
﹤0.01% 2008
2020
Q3
$815K Sell
11,432
-6,361
-36% -$453K ﹤0.01% 2045
2020
Q2
$1.46M Sell
17,793
-16,678
-48% -$1.37M ﹤0.01% 1686
2020
Q1
$2.03M Sell
34,471
-30,967
-47% -$1.82M ﹤0.01% 1326
2019
Q4
$6.76M Buy
65,438
+55,438
+554% +$5.73M ﹤0.01% 1046
2019
Q3
$202K Sell
10,000
-35,660
-78% -$720K ﹤0.01% 3053
2019
Q2
$1.18M Buy
45,660
+45,485
+25,991% +$1.17M ﹤0.01% 2218
2019
Q1
$2K Sell
175
-10,325
-98% -$118K ﹤0.01% 4144
2018
Q4
$30K Buy
+10,500
New +$30K ﹤0.01% 3292
2018
Q3
Sell
-36,500
Closed -$117K 4296
2018
Q2
$117K Buy
36,500
+900
+3% +$2.89K ﹤0.01% 3000
2018
Q1
$87K Buy
+35,600
New +$87K ﹤0.01% 3228
2017
Q4
Sell
-17,500
Closed -$97K 4065
2017
Q3
$97K Buy
17,500
+1,310
+8% +$7.26K ﹤0.01% 2715
2017
Q2
$89K Buy
16,190
+8,333
+106% +$45.8K ﹤0.01% 2812
2017
Q1
$30K Buy
7,857
+7,718
+5,553% +$29.5K ﹤0.01% 3255
2016
Q4
$1K Hold
139
﹤0.01% 3679
2016
Q3
$1K Buy
+139
New +$1K ﹤0.01% 3713